FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2590267070> ?p ?o ?g. }

• W2590267070 endingPage "4649" @default.
• W2590267070 startingPage "4649" @default.
• W2590267070 abstract "4649 Background: Neuroendocrine (NE) carcinoma cells may be associated with prostate cancer, more often in high grade tumors. Their significance in localized disease treated with radiotherapy (RT) remains uncertain. We conducted a clinicopathologic study to determine if RT patients with Gleason score 8-10 and a NE component are at risk for inferior outcomes vs. patients without NE features. Methods: Chromogranin (chromo) staining was attempted on core biopsies from 126 patients from the William Beaumont Hospital prostate cancer database. 99 had evaluable tumor in biopsy material. Patients received external beam RT alone or with high dose rate brachytherapy boost. Staining was quantified as 0%, < 1% (focal), 1-10%, or > 10% of tumor cells. Cox regression and Kaplan Meier estimates determined if the frequency of NE cells in core biopsy specimens correlated with clinical endpoints. Results: Median follow- up was 5.4 years. 27 patients had at least focal positive chromo staining. No significant differences existed between patients with or without staining in terms of age, pretreatment PSA, tumor stage, hormone therapy administration, % biopsy core involvement, or RT modality. Mean Gleason score was higher for the patients with absent chromo staining (8.4 vs. 8.2, p=0.04). Multivariate analysis showed chromo staining to adversely predict for PSA failure, distant metastases (DM), and cause-specific survival (CSS). At 10 years, DM rates were 13.1% for patients without and 51.3% for those with staining (p=0.005). CSS was 89.3% and 73.4%, respectively, for patients without and with chromo staining (p=0.001). Local recurrence was 7.3% without and 3.8% with chromo positivity (p=0.62). A trend toward an overall survival advantage was seen for patients without chromo staining with 5-year rates of 77.8% vs. 59.5% but 46.3% vs. 45.0% at 10 years (p=0.09). Results were similar when patients were grouped as < 1% vs. > 1% staining. Conclusions: For Gleason score 8-10 prostate cancer, the presence of NE carcinoma cells is associated with inferior clinical outcomes for patients treated with radiotherapy. This appears to relate most directly to an increase in distant as opposed to local failures. No significant financial relationships to disclose." @default.
• W2590267070 created "2017-03-03" @default.
• W2590267070 creator A5000289235 @default.
• W2590267070 creator A5025935885 @default.
• W2590267070 creator A5029804379 @default.
• W2590267070 creator A5034586842 @default.
• W2590267070 creator A5044146194 @default.
• W2590267070 creator A5050323560 @default.
• W2590267070 creator A5059255743 @default.
• W2590267070 date "2010-05-20" @default.
• W2590267070 modified "2023-10-14" @default.
• W2590267070 title "Neuroendocrine carcinoma in conjunction with Gleason score 8-10 prostate cancer: Clinical implications for patients treated with radiotherapy." @default.
• W2590267070 doi "https://doi.org/10.1200/jco.2010.28.15_suppl.4649" @default.
• W2590267070 hasPublicationYear "2010" @default.
• W2590267070 type Work @default.
• W2590267070 sameAs 2590267070 @default.
• W2590267070 citedByCount "2" @default.
• W2590267070 crossrefType "journal-article" @default.
• W2590267070 hasAuthorship W2590267070A5000289235 @default.
• W2590267070 hasAuthorship W2590267070A5025935885 @default.
• W2590267070 hasAuthorship W2590267070A5029804379 @default.
• W2590267070 hasAuthorship W2590267070A5034586842 @default.
• W2590267070 hasAuthorship W2590267070A5044146194 @default.
• W2590267070 hasAuthorship W2590267070A5050323560 @default.
• W2590267070 hasAuthorship W2590267070A5059255743 @default.
• W2590267070 hasConcept C121608353 @default.
• W2590267070 hasConcept C126322002 @default.
• W2590267070 hasConcept C126894567 @default.
• W2590267070 hasConcept C142724271 @default.
• W2590267070 hasConcept C143998085 @default.
• W2590267070 hasConcept C2775934546 @default.
• W2590267070 hasConcept C2776235491 @default.
• W2590267070 hasConcept C2777416452 @default.
• W2590267070 hasConcept C2777546739 @default.
• W2590267070 hasConcept C2780192828 @default.
• W2590267070 hasConcept C509974204 @default.
• W2590267070 hasConcept C71924100 @default.
• W2590267070 hasConcept C74864618 @default.
• W2590267070 hasConceptScore W2590267070C121608353 @default.
• W2590267070 hasConceptScore W2590267070C126322002 @default.
• W2590267070 hasConceptScore W2590267070C126894567 @default.
• W2590267070 hasConceptScore W2590267070C142724271 @default.
• W2590267070 hasConceptScore W2590267070C143998085 @default.
• W2590267070 hasConceptScore W2590267070C2775934546 @default.
• W2590267070 hasConceptScore W2590267070C2776235491 @default.
• W2590267070 hasConceptScore W2590267070C2777416452 @default.
• W2590267070 hasConceptScore W2590267070C2777546739 @default.
• W2590267070 hasConceptScore W2590267070C2780192828 @default.
• W2590267070 hasConceptScore W2590267070C509974204 @default.
• W2590267070 hasConceptScore W2590267070C71924100 @default.
• W2590267070 hasConceptScore W2590267070C74864618 @default.
• W2590267070 hasIssue "15_suppl" @default.
• W2590267070 hasLocation W25902670701 @default.
• W2590267070 hasOpenAccess W2590267070 @default.
• W2590267070 hasPrimaryLocation W25902670701 @default.
• W2590267070 hasRelatedWork W1725314107 @default.
• W2590267070 hasRelatedWork W2002697956 @default.
• W2590267070 hasRelatedWork W2041562209 @default.
• W2590267070 hasRelatedWork W2047986592 @default.
• W2590267070 hasRelatedWork W2095924422 @default.
• W2590267070 hasRelatedWork W2099948048 @default.
• W2590267070 hasRelatedWork W2143699516 @default.
• W2590267070 hasRelatedWork W2148869351 @default.
• W2590267070 hasRelatedWork W2417874801 @default.
• W2590267070 hasRelatedWork W3082324229 @default.
• W2590267070 hasVolume "28" @default.
• W2590267070 isParatext "false" @default.
• W2590267070 isRetracted "false" @default.
• W2590267070 magId "2590267070" @default.
• W2590267070 workType "article" @default.